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Abstract: In this article the Proteasome, Endoplasmic Reticulum and Mitochondria (PERM)
hypothesis is discussed. The complex machinery made by three homeostatic mechanisms involving
the proteasome (P), endoplasmic reticulum (ER) and mitochondria (M) is addressed in order to
elucidate the beneficial role of many xenobiotics, either trace metals or phytochemicals, which are
spread in the human environment and in dietary habits, exerting their actions on the mechanisms
underlying cell survival (apoptosis, cell cycle regulation, DNA repair and turnover, autophagy) and
stress response. The “PERM hypothesis” suggests that xenobiotics can modulate this central signaling
and the regulatory engine made fundamentally by the ER, mitochondria and proteasome, together
with other ancillary components such as peroxisomes, by acting on the energetic balance, redox
system and macromolecule turnover. In this context, reactive species and stressors are fundamentally
signalling molecules that could act as negative-modulating signals if PERM-mediated control is
offline, impaired or dysregulated, as occurs in metabolic syndrome, degenerative disorders, chronic
inflammation and cancer. Calcium is an important oscillatory input of this regulation and, in this
hypothesis, it might play a role in maintaining the correct rhythm of this PERM modulation, probably
chaotic in its nature, and guiding cells to a more drastic decision, such as apoptosis. The commonest
effort sustained by cells is to maintain their survival balance and the proterome has the fundamental
task of supporting this mechanism. Mild stress is probably the main stimulus in this sense. Hormesis
is therefore re-interpreted in the light of this hypothetical model and that experimental evidence
arising from flavonoid and hormesis reasearch.
Keywords: mitochondria; proterome; reactive oxygen species (ROS); oxidative stress; flavonoids
1. Introduction
PERM (Proteasome, Endoplasmic Reticulum and Mitochondria) is a new concept introduced to
define a functional structure, the “proterome”, described in this review, which should regulate the
survival decision of the cell upon oxidative stress. This structure is fundamentally a functional setting
of three major components existing within the living cell, namely the mitochondria, the endoplasmic
reticulum (ER) and the proteasome, associated also with the activity of peroxisomes, which altogether
participate in the complex stress response of cells. The main activity of the proterome is to
coordinate and modulate two fundamental mechanisms in cell survival, i.e., apoptosis and autophagy.
The proterome is a complex functional system arranged by the cell to organize its ability in addressing
autophagy or apoptosis. Researchers are still wondering how the complex machinery controlling cell
cycle and survival works despite the numerous external insults, which also encompass phytotoxic
xenobiotics. Usually reactive oxygen species (ROS) and reactive nitrogen species (RNS) are simply
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considered toxic or potentially damaging waste products, but they actually serve as major signaling
molecular species that allow the cell to trigger its survival machinery. ROS are even produced by plant
phytochemicals and xenobiotics. From this perspective, we probably have to dismiss some prejudices
about the role of antioxidant molecules, reactive oxygen species, cell stress response and survival
mechanisms. ROS may help cells to survive. In this sense, the proterome is a macrosystem that should
assist external ROS-inducing molecules with their fundamental activity of dampening stress-derived
damage. If moderated levels of redox reactive species are essential to the survival machinery of cells,
those species should act on the main functional system modulating cell survival. This system might be
essentially made by the proteasome, endoplasmic reticulum (ER) and mitochondria, the function of
which may be referred to as the PERM system or “proterome” (an acronym of proteasome, ER, and
chondriome). The proterome, prior to being demonstrated as an anatomical and dynamic structure, is
fundamentally a functional concept. Anyway, the physical concept of the PERM system or proterome
might yet lie in the possibility that mitochondria and the endoplasmic reticulum join together and
act functionally as a single macrosystem, as ER and mitochondria can form the mitochondria-ER
associated membranes or MAMs, modulating calcium signalling and autophagy [1]. These MAMs
are important platforms for the bioactivity of many signalling pathways leading to the modulation of
mitochondria biology. Therefore, the mitochondria, ER and proteasome may create a single structure
(the proterome) that should rule the decision either of autophagosome formation or the apoptosis
cascade, besides acting on the mitochondria fission/fusion dynamics [1]. The fundamental role of
the proterome or PERM system is to maintain cell survival through its biochemical and functional
machinery, which most probably adopts chaotic mechanisms leading to strange attractors. Some
evidence reported below would even suggest the physical though transient existence of an intracellular
PERM complex, which should activate the mechanisms explained in this review.
The activity of the proterome (PERM system) is summarized in Figure 1.
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may be created in order to help cells decide between autophagosome production and apoptosis. ER 
stress should be considered as a “buffer” system, where ROS synchronize with the activity of 26S-
proteasomes in order to reduce ER stress. When ER stress overwhelms a threshold value, then 26S-
proteasome disassembles. The reduction (scavenging) of ROS is made by the chaotic activity of 
CYP450 and by a 26S-proteasome (not shown). Most probably, in the usual condition, ER stress is the 
main trigger of proterome formation. Green positive symbols mean activation or induction, red 
negative ones are inhibition. The greater the ROS yellow flash, the higher the ROS concentration or 
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Figure 1. Suggested model for a protero e (PERM (Proteasome, Endoplasmic Reticulum and
Mitochondria) system). The endoplasmic r lum (ER) joins the osc llating mitochondria (the exact
topology should be further valuated) t e thr e main chaoti oscillators (in icat d by letters)
synchronize due to (A) stressors (ROS) accretion or persistence of the ROS-dependent stress; (B) Increase
in the percentage of oscillating mitochondria (related to inner membrane ∆ψ); (C) Perturbation in the
calcium oscillatory system. In these conditions, it is presumable that a proterome may be created in
order to help cells decide between autophagosome production and apoptosis. ER stress should be
considered as a “buffer” system, where ROS synchronize with the activity of 26S-proteasomes in order
to reduce ER stress. When ER str ss overwhelms a threshold value, th n 26S-proteasome disassembles.
The reduction (scavenging) of ROS is made by the chaotic activi y of CYP450 and by a 26S-proteasome
(not shown). Most probably, in the usual condition, ER stress is the main trigger of proterome formation.
Green positive symbols mean activation or induction, red negative ones are inhibition. The greater the
ROS yellow flash, the higher the ROS concentration or persistence. See text for further comments.
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2. Organelles and Signalling Molecules of the Proterome
2.1. Role of Flavonoids as Stressing and Signalling Molecules
Both chemical xenobiotics and plant-derived compounds may elicit reactive oxygen species (ROS)
in the cell and in doing so they have the fundamental purpose to release ROS into the mainstream
of signalling molecules, henceforth activating proterome function. Phytochemicals are plant-derived
bioactive molecules, often associated with the term phytoestrogens, phytonutrients or nutraceuticals,
which usually share aryl-hydrocarbon structures such as phenolic, polyphenolic or heterocyclic
backbones and together with environmental xenobiotics they exert a fundamental action on human
health [2–5]. Some more commonly known phytochemicals, such as flavonoids, have contributed to
the scientific literature about the effect of food components on the individual’s machinery devoted to
the complex homeostasis of cell survival, energy expenditure and response to stressors, often leading
to the overall benefit to the organism. Interestingly, this health-promoting effect may also be exerted
by a great deal of chemical xenobiotics at low doses, either as naturally derived compounds or even
chemicals coming from industrial pollutants, so expanding the debate in the research community about
the actual beneficial mechanism of these substances and the hormetic role of toxic pollutants in human
health [6]. Fundamentally, phytochemicals and xenobiotics from human industrial activity should
act as potentially toxic and noxious substances, the former because plants produce highly complex
biochemical compounds to face other organisms’ insults and predation, the latter because the human
body is unable to address the burden of pollutants released from anthropization. What is particularly
intriguing is that these substances, particularly if within a defined range of concentration, should act
as beneficial rather than toxic molecules. A recent theory suggests that, during the evolutionary course,
animals and fungi developed systems able to counteract their toxic or genotoxic action and potentiate
cell response to this stress, causing improvement in cell survival, a mechanism that would explain our
current ability to respond to industrial pollutants, if at low doses [7–11]. However, the mechanism by
which flavonoids act as beneficial substances in animal cells is still far from being fully elucidated.
Most of these phenolic compounds are yet known as molecular inhibitors. In a more general way,
phytochemicals inhibit several signaling pathways involved in at least three main mechanisms, i.e.,
inflammation, cell cycle/apoptosis and redox response/survival, such as PI3K/Akt/mTOR [12–16],
MAP kinases (MAPK) [17–19], ERK1/2 [20], Wnt/β-catenin [21] and NF-κB [22,23]. It appears quite
clear that these substances, which should act as toxic compounds in animals and fungi, as they are
produced from plants quite exclusively with a defensive purpose, must inhibit many cellular signalling
pathways. Interestingly, most of them exhibit a beneficial action of cell biology [24–27], apparently
despite their toxic nature.
Researchers worldwide are still concerned to elucidate the complex machinery leading to a benefit
rather than noxious effect in an organism and to understand its ability to modulate the very fine
balance between stressors’ accretion and the stress response aimed at scavenging stressors, when cells
are targeted by these plant-derived phenolics or by xenobiotics [28–31]. Usually, these compounds
are considered natural antioxidants and often collected within the same biochemical group that
usually includes vitamins [32–34]. However, this definition is not perfectly suitable to the huge and
highly heterogeneous panoply of substances (>8000) coming from plants, which might even behave as
toxic pollutants in their hormetic range [35,36]. Therefore, while their antioxidant ability is a possible
hallmark of their biological action, a much more complex role should be associated with these molecules
and xenobiotics when dealing with hormesis in cell survival. Plant phytochemicals, and likewise
pollutant xenobiotics, are able to target mitochondria as well as the endoplasmic reticulum (ER) and
the proteasome detoxifying activity [37–41]. Most probably the proteasome–ER–mitochondria system
(PERM) should act as a complex single machinery, where ROS and probably RNS, too, act as signalling
modulating molecules. This perspective would suggest that phytochemicals and pollutant xenobiotics,
particularly in a defined range of concentrations, activate complex cell machinery devoted to the
monitoring of cell survival, made up of the mitochondria–ER (peroxisome) and proteasome, where
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redox-generated molecules have a major signaling role. If phytochemicals and other external pollutants
(xenobiotics) are able to elicit proterome activity, ROS-generating systems, such as peroxisomes,
mitochondria and ROS-scavenging systems, within the cells are of major importance to address the
ability of cells to respond to stress and switch on survival functions.
2.2. Role of Peroxisomes
Both ROS and RNS are usually considered waste toxic species against which proper antioxidant
activity and cytochrome-mediated scavenging of ROS-derived stressors should act for cell survival.
This is partly true, yet ROS are also fundamental signalling molecules [42,43]. Xenobiotics may elicit
ROS, generating exogenous-borne reactive species, which should add to their action with endogenous
ROS [44]. In this context a major role is exerted by peroxisomes, which are at the crossroads of the
stress response and mitochondrial function [45–48] and more likely because, at least as observed
in plants, peroxisomes participate in regulating ROS and RNS-mediated signalling networks [49].
Furthermore, they even may be a source of ROS as signalling molecules [50]. In mammalian
cells, redox molecules from peroxisomes target the mitochondria [51] and therefore a fundamental
relationship might exist between redox signalling from the peroxisome and mitochondria. What is
well known is that peroxisomes are eukaryotic organelles that contribute to the breaking down
of fatty acids (FAs), encompassing both long-chain and branched-chain FAs, for the subsequent
β-oxidation in mitochondria and use oxygen to produce ROS and scavenge ROS themselves via the
enzymatic anti-oxidant endowment [52]. Lon protease isoforms, LonP1 in mitochondria and LonP2
in peroxisomes, appear to play a major role in this relationship [52]. Lon proteases are a family
of proteases that are found in Eukaryota but also in Archaea and Eubacteria and are ATP-dependent
serine proteases, belonging to the MEROPS database peptidase family S16, mainly present in the
mitochondria matrix [53,54]. Their role in the ROS-signalling pathway and related functions leads
to a modulation in the role exerted by mitochondria on cell survival, and thus might be much
more intriguing than expected. Mutations of mitochondrial LonP1 may induce the multi-systemic
development disorder causing Cerebral, Ocular, Dental, Auricular, and Skeletal anomalies (CODAS
syndrome) [55]. The role of these proteases, therefore, might be fundamental as a functional link
between peroxisomes and mitochondria. What appears as a fundamental task of mitochondria, in
the relationship with peroxisomes, ER and proteasome, is the removal of oxidative modified proteins
and damaged proteins, a crucial process to maintain cell survival and homeostasis. Lon proteins
appear to have a major role in this mechanism, as Lon levels have been associated with ageing and
senescence, where senescent cells often lose their intrinsic ability to induce Lon expression during
acute stress [56,57]. It would appear that ROS may act as a signal in this Lon upregulation in response
to stress [58], and that ROS-dependent apoptosis is controlled by mitochondrial Lon proteases [59].
Although this evidence was reported to date only in certain cell models, it may serve as a conceptual
framework to comprehend how ROS act as signal molecules to elicit protective or pro-survival
mechanisms in which mitochondria play a role. The role of peroxisomes in this context is to balance
the amount of ROS in order to elicit a cell stress response and the role of Lon proteases might be
intriguing, deserving further insights in next future.
2.3. Role of the Proteasome
Furthermore, a metabolic interplay exists between peroxisomes and other intracellular organelles,
whereby peroxisomes are involved in the ROS/RNS metabolism [60]. Reactive nitrogen species
(RNS) participate with ROS to create proteomic homeostasis, and an imbalance in the redox state
may disrupt the proteostasis network [61]. If the activity of ROS as signalling molecules may target
the PERM system, then activities of ROS should be shown in the macromolecules participating
in the same system. Oxidative stress regulates proteasome activity [62]. In the model proposed
by Aiken et al., the mild stress condition should activate 26S proteasomes while with persistent
ROS-dependent insult, the proteasome should disassemble into 20S core particles (CPs) and 19S
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regulatory particles (RPs) [62,63]. When this dissociation occurs, free 20S proteasomes, which are
henceforth activated, will degrade oxidized proteins via a pathway working independently from the
involvement of ubiquitin and ATP [62]. Yet, the relationship between ROS and ubiquitin–proteasome
systems (UBS) is not a true novelty [64–67]. ROS can modify some reactive Cys residues (i.e., Cys273,
Cys288 and Cys151) in the Kelch-like ECH-associated protein-1, known as Keap1, a substrate adaptor
protein for a cullin3-dependent E3–ubiquitin ligase complex, so leading to the inhibition of the
ubiquitination and degradation of Nrf2, IKKβ and Bcl2/Bcl-xL [64]. The role of 26S proteasome is
intriguing in this context. This 25 MDa protein macrocomplex, made up of at least 31 subunits, finely
regulates protein degradation [68]. The 26S proteasome disassembles upon mitochondrial stress [69];
conversely, the mitochondria participate in regulating the activity of the proteasome [70]. In this sense,
the proteasome is finely linked with activity in response to mild stress, which should activate a higher
degradation of unfolded or damaged proteins and allow cells to maintain their functional integrity.
2.4. Role of Mitochondria
The role of mitochondria in this context is of the utmost importance. Many aspects will
be discussed below. Mitochondria turnover and homeostasis, particularly the fission and fusion
mechanism, are strictly associated with the proteasome activity. The homeodynamic balance between
fission and fusion is a fundamental hallmark of cell survival and protein homeostasis. The interaction
between the mitochondria outer membrane molecule mitofusin-1 (Mfn1) and the ubiquitin E3
ligase Mahogunin Ring Finger-1 (MGRN1) is, for example, critical for cell function, as defects
in this mechanism, such as those caused by the absence of MGRN1, lead to neurodegenerative
pathologies [71]. This would mean that the participation of the ubiquitin–proteasome system in the
mitochondria biogenesis and homeostasis represents a crucial function in the apoptotic vs. autophagy
balance [72–74]. Therefore, reactive species coming from oxidative stress may be particularly involved
in the peroxisome–ER–mitochondria relationship [75]. Mitochondria might be the functional engine of
the proterome. Their ability to create an oscillatory system, described below, gives the opportunity
to the chaotic system made by those organelles involved with ROS balancing, i.e., peroxisomes,
endoplasmic reticulum (ER) and the proteasome, to give cells their chance to choose autophagy
(mitophagy) or apoptosis, through the activity of the proterome.
2.5. Role of the Endoplasmic Reticulum (ER)
The endoplasmic reticulum (ER) plays a major role in controlling and regulating the dynamics
and amount of ROS. Furthermore, ER plays a major role in the introduction of calcium in the proterome
activity. The fundamental source of the intracellular calcium signalling is the endoplasmic reticulum
(ER), which therefore participates actively in this dynamics, even involving mitochondria [76].
The role of the ER is of major importance in controlling the switch to autophagy rather than
apoptosis, behaving as a master tuner of this bifurcation, principally thanks to calcium. The role
of ER in the apoptosis/autophagy balance, i.e., in that critical decision-making that cells exert
in order to die or survive, has been actively investigated in certain critical models, such as the
hypoxia/reperfusion injury [77]. In this model, the proteasome is also involved. The inhibition of the
26S proteasome strengthens autophagy but increases ER stress while reducing both apoptosis signals
and the inflammatory response. A very similar effect is obtained if simply promoting autophagosome
formation [77]. This would suggest the existence of an interesting link between ER stress and autophagy,
i.e., an inhibition of the autophagic signals, while existing ER stress (probably through a PERK or
IRE-1-dependent mechanism) should lead to apoptosis with theaid of calcium signaling [78]. Both ROS
and cell calcium signals regulate the activity of the proterome, in order to shift cell homeostasis to the
survival response (autophagy) or the death response (apoptosis), this latter to prevent further damage
to an organ or the whole organism.
The activity of ROS on ER may lead to ER stress, mitochondria dysfunction and apoptosis cascade,
for example by triggering the activity of ER stress markers such as 78-kDa glucose-regulated protein
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(GRP78), caspase 12 and C/EBP-homologous protein (CHOP), resulting in a mitochondria-mediated
apoptotic signaling. This cellular “choice” is most probably the effect of an ROS-mediated imbalance
in the proteostasis, i.e., the homeostasis of the protein degradation/synthesis, as occurs in cancer
cells, where notoriously antioxidant substances, such as the stilbene resveratrol, if associated with
a chemical xenobiotic, lead to the apoptotic event [79]. The question is whether this ER stress possesses
some functional “threshold” or “switch tuners” for which cells decide to suicide through a damaged
mitochondrial endowment or not. A possible answer should come from those tumour cell lines
expressing a methotrexate resistance phenotype. In these in vitro systems, cells rescued their survival
property through the PERK/ATF4 axis via the ER stress, which shifted the apoptosis/autophagy
balance towards the latter. The “switch” was performed by the JNK/p62 signalling pathway [80].
The endoplasmic reticulum has two major resident proteins, namely PERK and IRE-1, the sustained
activation of which leads to two different and quite opposite functions—apoptosis or cell proliferation,
respectively—probably through a calcium overload and the Ca2+ transient signalling between the ER
and mitochondria [81–83].
3. Proterome Function
3.1. The Role and Activity of the Proterome in the Autophagy/Apoptosis Balance
How does the proterome work? ROS are produced by various sources, either physical or chemical
in nature. In summary, the role of the proterome is to dynamically regulate the chaotic mechanism
leading to either autophagy or apoptosis. It uses ROS as signalling molecules and controls their
ability to induce mild stress by acting on the chaotic system generated by mitochondria, ER and
the proteasome and fed by the oscillatory system generated by the mitochondria and calcium.
Autophagy dampens ER stress through the clearance of ubiquinated proteins and switching off
the pro-apoptotic signal generated by too much ROS or an impaired calcium efflux. Factors causing
early ER stress increase the expression of p62, then cause its downregulation through the increase of
78 kDa glucose-regulated protein (GRP78), microtubule-associated protein1 light chain3 (LC3), inositol
requiring enzyme1 (IRE1), IRE1α, beclin and also p-JNK, leading to autophagy via the regulatory
pathway IRE-1/JNK/beclin [84]. Actually, autophagy is an alternative way of programmed cell-death
and ER stress is the real master tuner, able to switch on autophagy or apoptosis depending on the
mitochondrial stability. Some signalling pathways serve this purpose; for example, ER stress leads to
autophagosome formation, involving LC3 conversion via either PERK signalling (for example, the
PERK/eIf2a pathway) or the JNK pathway (i.e., the IRE-1/JNK pathway) [85]. In this scenario, the
role of tuners is most probably exerted by two major pathways, IRE-1 and PERK. Inositol-requiring
enzyme 1 (IRE-1) modulates ER stress in its “protein” face, namely the ER transmembrane sensor that
activates the unfolded protein response (UPR) [86]. UPR generates ROS and, if not properly and fully
addressed, leads to apoptosis.
The role of ROS in this context is therefore fundamental.
This quite complex scenario would suggest that ROS are most probably used as “calibrators”
or as the “checks and balances” adopted in a steelyard to allow cells to maintain survival functions
and decide to turn on autophagy of damaged organelles (mitophagy, for example) or apoptosis,
through the ER stress and mitochondria impairment, which drives and modulates the activity of
proteasome. The actual messenger in this system should be ruled by the oscillatory peaks of the
intracellular calcium [87–90]. Figure 2 summarizes the main biomolecular mechanisms involved
in the mechanism. The fundamental engine of this complex machinery might be some mechanism
underlying the synchronization of mobile chaotic oscillator networks, or at least their interaction [91].
It is tempting to speculate that the proterome should self-organize when ER stress reaches a critical
cutoff point, and calcium signalling would probably elicit, and then enhance, this mechanism. Anyway,
besides calcium, ROS also participate within the cell in the building up of an oscillatory network,
involving mitochondria [92,93]. This oscillatory behaviour, linking ROS and mitochondria, is also
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associated with the circadian rhythms [94], therefore making this cellular mechanism fundamental to
cell survival and growth. ROS have recently been mathematically modelled as fundamental elements
of a two-dimensional network, interacting with the oscillatory mitochondria network. This would
mean that, when stress occurs, causing an abrupt collapse of the PERM homeostasis or oscillations
of the mitochondrial biodynamics, their energy state is synchronized through the mitochondrial
oscillatory network by local interactions dependent on ROS [95,96]. These mechanisms suggest the
presence of a self-organized macro-structure, such as the proterome. Table 1 summarizes the main
chaotic mechanisms underlying the function of the proterome in the context of cell stress response and
its relationship with phytochemicals.
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as signal molecules. Lysosome Lon proteases activate mitochondrial Lon homologues, which dampen
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membrane potential, which is initially modulated and maintained (through a synchronization) by ROS
of ER stress, which also activates the scavenging of stressors by lysosomes. This is a major hub in
the cell homeodyn mics, because the choice between mitophagy and apoptosis d pends on the many
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Table 1. Chaotic behaviour of some signalling pathways and macromolecular systems in the activity
of proterome.
System Description Working Structure References
CYPs-ROS Murburn hypothesis Small amounts of ROS are able to switch on the chaoticnetwork of cytochrome P450 groups [61,62]
ROS-mitochondria Chaotic synchronization ofoscillation networks
The macroscopic property of the mitochondrial network is
reproduced in a reaction-diffusion model of ROS-induced
ROS-release
[97]
ROS-calcium
Chaotic interplay Sub toxic levels of ROS interplay with calcium signalingnetwork [92]
Calcium oscillations
On the basis of the permeability of the ER channels and on
the kinetic properties of calcium binding to the cytosolic
proteins, different patterns of complex calcium oscillations
occur
[47]
Proterome
Chaotic synchronization Synchronization of mobile chaotic oscillators in thebi-dimensional landscape [98]
ROS signalling Participation in the synchronization process [99–101]
Mitochondria Dynamics in the network [102–104]
Proteasome and
chaperones Chaotic-type oscillatory system depending of ATP levels [105]
3.2. Activity of the Proterome: ROS as Signalling Molecules and the Role of Xenobiotics
It is widely accepted that the effect of plant-derived chemicals, also called phytochemicals, and
low-dosed chemical xenobiotics is to promote cell response to stress, thereby eliciting a positive
and beneficial outcome on cell survival. Furthermore, both phytochemicals and xenobiotics are able
to produce ROS. In this PERM hypothesis these compounds might act as “perturbing agents” of
the chaotic oscillatory systems driving cell homeodynamics to reach its functional attractor, which
should lead either to survival pathways, autophagy (mitophagy) or apoptosis (see also above). We
have suggested that this machinery adopts both calcium and ROS as important signalling mediators.
Phytochemicals may enter the cell principally through the aryl-hydrocarbon receptor (ArHR) [106,107].
The relationship between ArHR and ER stress has recently been reported in a mast cell model, where the
activation of ArHRs with ligands led to ROS and calcium signalling. Calcium peaks in the oscillatory
system caused by the ArHR activation are regulated by the SHIP-2 phosphatase, which therefore is
critical for the activation of the ER stress and intracellular calcium, in response to the ArHR-mediated
signalling [108]. In this model, a ligand of ArHR activates SHIP-2, which in turn promotes, via
ROS-mediated signalling, an ER stress response that involves the PERK signalling pathway and also
the ATF4 activation and eIF2α phosphorylation [108]. This is most probably a “perturbing signal”
caused by the ArHR ligand to the PERM chaotic dynamics. Actually, this perturbation seems to be
“restored” by the activity of N-aceyl-L-cysteine (NAC), a well-known antioxidant [108].
As ligands of ArHR are also antioxidant molecules, this mechanism merits further discussion.
The mast cell model shows that ligands of ArHR initially cause a calcium signal, then a ROS signal and
an ER stress response. In the PERM hypothesis we suggested here, the ArHR ligand “perturbs” the
homeodynamic machinery made by the activity of the proteasome, ER and mitochondria, where ER
can be considered the dynamic pivot of the system. Probably, phytochemicals are good inducers of the
proterome formation. The proterome thus has to be considered as a single functional macrosystem in the
cell, able to drive cells to pro-survival decision-making. Actually, the antioxidant effect in normal cells or
the pro-apoptotic effect in tumour cells seem to confirm this suggestion, i.e., cancer cells most probably
lose their ability to respond to stress and ER stress leads to the apoptotic event [109]. It is intriguing that,
while relatively low doses of xenobiotics, radiation and phytochemicals activate the survival machinery
in normal, healthy stress-responding cells, those doses are able to trigger apoptosis in cancerous ones.
The concept of “hormesis” has been suggested to explain how neurotoxicants, pollutants or genotoxic
substances, able to trigger a redox signaling and ROS production, exert a beneficial action on cells in
certain doses or a pre-conditioning state [110–113]. As these substances are intrinsically noxious, as
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plants produce them as a defensive mechanism against predators and pollutants are rarely common in
the body’s original composition, then their beneficial or detrimental activity depends only on the system
homeodynamics or, otherwise, on the system’s chaotic behaviour with its bifurcation.
3.3. Mitochondria in the Proterome Activity
It is arguable that the critical step in the PERM system may be represented by the ER stress, to
which the proteasome activity should also be related. A possible factor able to increase the activity
of proteasome under ER stress condition is the inactive rhomboid protein 1 (iRhom1), which is
known also as rhomboid 5 homologous 1 or rhomboid family member 1 (RHBDF1) [114]. Stressors
able to induce ER stress are also able to enhance iRhom1 expression and activity, thus leading to
its interaction with the 20S proteasome associated ER-resident chaperones PAC1 and PAC2 and
increasing proteasome activity [114]. Rhomboid proteases are probably the most intriguing recent
targets of our investigation on PERM function. Their activity might be fundamental to elucidating
the activity of PERM or the proterome. Besides the above mentioned iRhom1, mitochondria also
have rhomboid proteases, called presenilin-associated rhomboid-like protease or PARL proteases,
which should accomplish complex functions associated with the maintenance of the mitochondria
steady state and homeostasis, related to the stress response [115,116]. The role of PARL proteases is
fundamental for the regulation of mitochondria function and stress response, as PARL is a master
tuner of the mitochondria’s ability to respond to stress [116]. Therefore, the newest suggestion for
PERM activity includes the role of rhomboid proteases. These molecules should serve as fundamental
switching tuners to apoptosis or autophagy in the PERM function. PARL activity is also involved in the
mitophagy process [98]. When mitochondria have a high ∆ψm, as occurs in polarized mitochondria
with preserved mitochondrial potential, usually PARL, which is located in the inner mitochondrial
membrane, cleaves the serine/threonine kinase PINK1, which is imported through the TOM/TIM
complexes, and probably also cleaves PGAM5 and OPA1 [115]. Notably, PGAM5 is an AIF-associated
factor and triggers caspase activation and cell death [99], and OPA1 controls cristae remodelling
during apoptosis; however, what is very interesting is that OPA1 belongs to a wide group of proteins
(mitofusins, proteins of the Kif family, Bax, Fis1 and Drp1) that link the chaotic oscillatory mechanism
of the mitochondria fission/fusion with processes altering the mitochondrial membrane potential,
leading to apoptosis if dysregulated and autophagy if finely regulated [100]. When mitochondria have
a low ∆ψm, i.e., in depolarized mitochondria or particularly when mitochondrial potential collapses,
PARL is unable to cleave PINK1, as it is no longer transported into the membrane by the TOM/TIM
system, leading to PARKIN recruitment into the cytosol and the activation of mitophagy, in order to
eliminate damaged mitochondria [115,117]. The system suggests that membrane potential cannot be
the only trigger able to lead cells to the apoptotic cascade, as mitochondria are mainly induced to be
autophagocyted, prior to leading to cell death by an apoptotic mechanism.
Substances inducing ER stress are fundamental in this dynamics.
3.4. Calcium Oscillation and Proterome Chaotic System
The model presented here suggests that ROS, particularly if eliciting a mild stress, are controlled
by the ER activity, in conjunction with peroxisomes and mitochondria, and modulating the activity
of proteasome, in order to maintain cell survival, often leading to an autophagic mechanism to
safeguard cell integrity. Therefore, in this model, the self-assembly of the proterome depends on the
ER stress/mitochondria relationship, which is often regulated by ROS.
The flavonoid interacting with the ArHR should induce an initially attenuated ER stress, which
can cause a moderate loss of the mitochondrial ∆ψ. The overexpression of Bcl-2, together with a
deficiency in caspase 9 and caspase 2, reduces this ER stress-mediated loss [101]. ROS activate the
26S-proteasome and this should induce an increase in the level of Bcl-2, as previous data showed that
the inhibition of 26S proteasome induces a decrease in Bcl-2 [97]. The role of Bcl-2 may be intriguing
in this context: cancer cells are often dysregulated in the apoptotic response but the persistently
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low Bcl-2/Bax ratio might even promote the pro-apoptotic effect of phytochemicals. Conversely, the
inhibition of proteasome also leads to apoptosis, a mechanism that may explain the role of p53 and the
consequent upregulation of PUMA and Bim [118].
Yet, the scenario is most probably much more complicated than that.
The moderated stress response also generated the concept of “mitohormesis” [119,120].
Mitochondrial hormesis is represented as a non-linear response to ROS, which are considered
well-known signalling inputs, even in plants [121,122].
In the PERM mechanism, the production of ROS and the intracellular calcium overload should
lead to the depolarization of the mitochondrial inner membrane potential (low ∆ψm) and subsequent
cell damage. How can this mechanism, involving as it does only a few mitochondria (mitohormesis),
drive all the cells to a fatal or survival decision? In cardiac myocytes, where the chaotic oscillations
are more evident, it was reported that synchronized and self-maintaining oscillations occur in the
∆ψm of the inner membrane and involve ROS and NADH in at least 70% of the chondriome, i.e.,
almost the total endowment of active mitochondria in the cell [123]. These oscillations, which
could be synchronized, started after about 40 s of lag time, i.e., after a specific threshold level of
mitochondria-produced ROS was exceeded [123]. Initially, this mechanism does not involve calcium
overload. Therefore, this assesses the hypothesis that a threshold exists, at least in terms of ROS
and that calcium enters the system in a second time. Actually, at least in the cardiomyocyte model,
only 0.3% of mitochondria initially depolarize, creating a local perturbation in the functionality of
mitochondria. This local perturbation, triggered and maintained by ROS, generates an oscillatory
mechanism, depolarization/hyperpolarization, in a synchronized manner, after a lag time, probably
depending on the exceeding of the ROS threshold [123]. In this condition, the simple existence of an
independent mitochondrial functional network should lead to rapid cell apoptosis, if this network
is not modulated and buffered by the relationship with proteasome and ER stress. This might partly
explain why toxicants such as heavy metals, xenobiotics or phytochemicals act in pro-apoptotic,
pro-oxidant compounds when they are at a high dosage. During this oscillatory mechanism, the
proteasome contributes to the regulation of the process through the activity of parkin, a ubiquitin
E3 ligase. In dysfunctional mitochondria, when oscillations are synchronized to lead to a greater
number of depolarized mitochondria, parkin activates the ubiquitin–proteasome system (UPS), which
induces the proteolysis of the outer membrane proteins of mitochondria and leads to mitophagy [124].
The same parkin is able to promote the degradation of ARTS, known also as Sepr4_i2, a mitochondrial
protein that may initiate the apoptotic cascade through the activation of caspases upstream from the
cytochrome c release [125].
Calcium is in this context most probably used to irreversibly turn cells to an apoptotic decision.
We are yet unable to verify if calcium oscillations may inter-relate with other oscillatory systems, such
as mitochondria or ROS/proteasome, to modulate cell decision making. This should occur particularly
when stressors overwhelm the chaotic mechanism of intracellular balance ruled by the proterome.
The system as a whole should therefore work as a dynamical chaotic oscillator. Synchronization is
a classical non-linear phenomenon, occurring widely in biology and chaotic oscillators can be studied
by the concept of phase applied to the case of continuous time-chaotic systems. Moreover, any type of
synchronization can be considered, in a general way, as the appearance of some additional order inside
the dynamics. For chaotic systems, this would mean that the dynamics in the phase space is restricted
to a symmetrical sub-manifold. Therefore, only from the point of view of the topological properties of
chaos, the synchronization transition usually means that simplification leads to the structure of the
strange attractor. Chaotic systems having a strange attractor structure promote new synchronization
with other systems [126–128].
Despite the fact that the proterome or PERM system is still speculative, many recent findings
suggest the existence of a macrostructure linking the mitochondria, ER and proteasome, adapted to
respond to stress in a chaotic oscillatory synchronization and leading cells to their major decision,
usually translated into an autophagic or apoptotic event.
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3.5. Chaotic Activity Elicited by ROS in the Proterome
In this scenario, the early pro-oxidant activity exerted by xenobiotics and phytochemicals may
give important insights into the issue, probably contributing to elucidate the complex mechanism
underlying how cells control redox signaling. The commonest opinion is that flavonoids act
as pro-oxidant molecules at a very high dosage and that this activity could be related to their
chemical flavone and/or polyphenolic backbone and chemical substituents [127]. Our opinion is
that, in the context of the U-shaped curve of the hormetic dose response, these phytonutrients
act as mild pro-oxidant molecules at relatively low dose ranges (picomolar–micromolar), as
antioxidants at sub-micromolar/micromolar ranges (the U-bottom) and as pro-oxidants at high
dosages (micromolar-millimolar). Actually, the pro-oxidant activity of flavonoids has recently been
reviewed [128]. Xenobiotics and phytochemicals have, therefore, a pro-oxidant activity [102,129,130].
In the so-called “Murburn hypothesis”, Manoj et al. reported that small amounts of diffusible reactive
oxygen species or DROS are fundamental to making the CYPs machinery involved in the redox
metabolism of liver microsomes work [129], hence the generation of small amounts of ROS within
the cell is required for the housekeeping metabolism [129]. Manoj and co-workers stated that the
mechanism involving these species is chaotic [129]. In this chaotic system, DROS may work aside from
the catalytic centre of detoxifying enzymes, i.e., there is no obligation for a substrate or an inhibitor to
react with the heme centre and influence the overall mechanism of catalysis, and in this sense ROS
are not only substrates but finely acting regulators of the cytochrome-redox activity [130]. A chaotic
behaviour was reported in past years on peroxidase [102,131] and some researchers suggested that
an increase in the concentration of reacting species should lead to imperfectly mixed systems with
both stochastic and chaotic behaviour [130]. If the system underlying the redox machinery is made of
a particular topology of the network built up by different switches with fluctuating response times,
then it may lead to a defined cell activity. This event probably depends on the “noisy” level of ROS
signalling, i.e., when the elements making the network functional tend to synchronize by suppressing
fluctuations, they lead to reliable dynamical attractors [132]. In other words, the mild, finely regulated
working of routinely produced ROS may lead to a chaotic system that is synchronized by an external
factor to reach a reliable dynamical attractor, i.e., an irreversible cell response. Our hypothesis is
therefore that ROS are finely tuned to maintain a chaotic oscillatory system, synchronized with
mitochondria and calcium, in order to allow the cell to stay in a homeodynamic state, which should let
it respond promptly and properly to any stressful stimulus. Proterome makes this possible. On the
other hand, an unreliable dynamical attractor may come when networks desynchronize, as may
occur when the chaotic system changes to a more stochastic system, i.e., when the concentration
of the reactive species is too high or persistent due to defects in the scavenging systems [102,132].
Very recently, the hypothesis of so-called “mild oxidative stress” should explain the role of ROS in
sperm telomere length maintenance, showing a delicate balance in the dynamics of telomere structure
by ROS levels [133–135]. In this context, ROS, induced by physical or chemical stress, are formidable
signalling molecules of the homeodynamic activity of the proterome.
The “PERM hypothesis” we are formulating here, while suggesting the existence of a new
macrosystem called the proterome, starts from the fundamental consideration that ROS are major
signalling molecules in the regulation of the survival process of the cell [136]. Therefore, paradoxically,
this seems to be the main functional role of ROS, though they are also waste by-products of protein
turnover and the mitochondria redox mechanism. Cells use ROS as subtle signals of the many inputs
coming either from outside or inside the cell, even electromagnetic fields [103,137]. Their relationship
with mitochondria is particularly intriguing.
An emerging functional relationship between ROS or oxidative stress, mitochondria and autophagy
has recently been reviewed [138]. This relationship should also shed a light on mitochondria-triggered
apoptotic mechanisms. The early generation of ROS is a critical step for mitochondrial damage, which
may activate the intrinsic apoptotic pathway, but early ROS can be regulated by autophagy [139].
Both chemical and physical stressors, such as electromagnetic fields and ionizing radiation, generate ROS
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but also elicit a panoply of signalling molecules that regulate autophagy, i.e., PARP1, sirtuins, FOXO-3a,
ATM and mTOR, and increase ceramide and intracellular calcium [104]. Initially, ROS should interact
with the PERM system through the peroxisome’s calcium signalling. It is well known, although still
under investigation in plants, that peroxisomes “sense” the chaotic level of ROS/RNS and other
nitrogen-related species, such as NO, and act as decision-making platforms to adjust cell function
towards the most correct and proper response to stressors [49]. Peroxisomes themselves produce ROS
as signal molecules [47,50]. The initial triggering of the calcium signal most probably switches on the
starting engine of the complex interplay between calcium and ROS, two master tuning systems within
the cell, both chaotic and oscillatory, which modulate many important signalling pathways [105].
4. Conclusions
PERM is a functional terminology to indicate a complex dynamical system made up of the
proteasome, endoplasmic reticulum (ER) and mitochondria, which has been called the proterome.
Most probably this system acts as a single master tuner of cellular decision-making about life or death,
in order to give a chance to the remaining living cells in an organism. The ability to adapt its dynamics
to the huge number of stressors, insults and stimuli may lie in its chaotic behaviour, mainly formed by
synchronized oscillatory mechanisms, which involves several important components of the proterome,
such as calcium, ROS and mitochondria polarization of the inner membrane. The synchronization
of at least two chaotic oscillatory systems should lead to a bifurcation point that results in a final
functional action, usually divided between the decision to eat damaged organelles (mitophagy) and
hence survive, or to die (apoptosis). Many interesting and newly discovered proteins participate in
this modulation. Xenobiotics and phytochemicals can perturb this modulation and lead to cell injury
when the system is dysregulated (cancer or damaged cells) or when the stimulus is exacerbated or
persistent, while, under a threshold level, they act indirectly, potentiating the ability of the PERM
system to counteract damaging signals.
This overview of mitochondria as a component of a more complex system including the
proteasome and ER may improve our understanding of the role and activity of flavonoids and
xenobiotics in human health, though further experimental investigations are needed to assess and
improve the elucidation of these models.
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